MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages

Department of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, Peoples Republic of China.
Cardiovascular Research (Impact Factor: 5.94). 05/2009; 83(1):131-9. DOI: 10.1093/cvr/cvp121
Source: PubMed


The inflammatory responses of monocytes/macrophages and the stimulation of lipid uptake into these cells by oxidized low density lipoprotein (oxLDL) are critical to the initiation and development of atherosclerosis. Increasing evidence has demonstrated that many microRNAs play important roles in the cell proliferation, apoptosis, and differentiation that accompany inflammatory responses. However, whether microRNAs are associated with monocyte/macrophage inflammatory responses or oxLDL stimulation is not yet known. The aim of the present study is to investigate microRNAs in monocytes/macrophages and their potential role in oxLDL-stimulation of lipid uptake and other atherosclerotic responses.
Microarrays were used to analyse the global expression of microRNAs in oxLDL-stimulated human primary peripheral blood monocytes. Expression profiles of the microRNAs were verified using TaqMan real-time PCR. Five microRNAs (microRNA-125a-5p, microRNA-9, microRNA-146a, microRNA-146b-5p, and microRNA-155) were aberrantly expressed after oxLDL treatment of human primary monocytes. Bioinformatics analysis suggested that microRNA-125a-5p is related to a protein similar to ORP9 (oxysterol binding protein-like 9) and this was confirmed by a luciferase reporter assay. MicroRNA-125a-5p was found to mediate lipid uptake and to decrease the secretion of some inflammatory cytokines (interleukin-2, interleukin-6, tumour necrosis factor-alpha, transforming growth factor-beta) in oxLDL-stimulated monocyte-derived macrophages.
MicroRNA-125a-5p may partly provide post-transcriptional regulation of the proinflammatory response, lipid uptake, and expression of ORP9 in oxLDL-stimulated monocyte/macrophages.

Full-text preview

Available from:
  • Source
    • "Modulation of vascular inflammation and angiogenesis (Grundmann et al, 2011) miR-125a Modulates capture of oxLDL by macrophages (Chen et al, 2009) miR-127 Modulation of vascular inflammation and oxidative stress (Santovito et al, 2012) miR-133a, miR-145 Regulation of vascular remodeling and inflammation by controlling VSMC proliferation and differentiation (Torella et al, 2011; Cordes et al, 2009) miR-155 Modulation of endothelial dysfunction, macrophages differentiation and lipid uptake in oxLDL (Huang et al, 2010) miR-221 Promotes reendothelialization and neo-angiogenesis (Davis et al, 2009) oxLDL, Oxidized low-density lipoprotein; VSMC, vascular smooth muscle cell. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Embolization of carotid stenotic plaques is the direct cause of stroke in nearly 20% of cases. Genetic mechanisms and especially the roles played by microRNAs in the regulation of plaque destabilization and rupture are mostly unknown. The aim of this pilot study was to compare the expression of seven microRNAs allegedly involved in plaque growth and instability (miR-100, 125a, 127, 133a, 145, 155, and 221), between symptomatic and asymptomatic human carotid plaques. Thirty patients undergoing carotid endarterectomy in our department were prospectively included. Carotid plaques were subdivided into symptomatic (n = 15) and asymptomatic (n = 15) according to the presence or absence of stroke. After isolation of total RNA from atherosclerotic plaques, microRNAs were quantified by real-time polymerase chain reaction. The two groups of patients were comparable in terms of age, gender, risk factors for cerebral ischemia, medication, and stenosis severity. All seven microRNAs were quantified in extracted carotid plaques. miR-100, miR-125a, miR-127, miR-133a, miR-145, and miR-221 were significantly overexpressed in symptomatic vs asymptomatic plaques. miR-125a expression was significantly inversely correlated with the circulating level of low-density lipoprotein cholesterol in the symptomatic group. This pilot study evaluated the expression of seven selected miRNAs in human carotid plaques from a small group of patients and suggested a potential regulatory role for these miRNAs in evolution of the plaque towards growth, instability and rupture. Studies based on larger sample sizes are required to determine the potential use of miR-100, miR-125a, miR-127, miR-133a, miR-145, and miR-221 as biomarkers or therapeutic targets for stroke. Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
    Full-text · Article · Jul 2015 · Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter
  • Source
    • "Several studies suggest the involvement of miRNAs in cardiovascular development and disease, and specifically miRNAs have been shown to influence heart formation [1], vascular development [2e4], smooth muscle differentiation and phenotypic modulation [5]. Furthermore, miRNAs have been demonstrated to be involved in cardiovascular diseases like myocardial infarction [6], cardiac hypertrophy [7e9], and atherosclerosis [10]. Endothelial cellspecific miR-126 modulates the expression of Vcam1 to regulate tumor necrosis factor-aestimulated leukocyte adherence to endothelial cells and vessel inflammation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The pathophysiology of coronary atherosclerotic plaques is a complex process. Early detection of coronary atherosclerotic plaques is critical in the prevention, prognostic and therapeutic intervention of cardiovascular disease. MicroRNAs (miRNAs), endogenous short non-coding RNAs, have been reported to play an important role in cardiovascular diseases and are also used as disease markers. However, the miRNA expression profile in early coronary atherosclerotic plaques has yet been reported. We hypothesize that miRNAs can be used as effective disease markers for detection of early coronary atherosclerotic plaques. In this analysis, coronary artery samples from three patients with early coronary atherosclerosis were harvested and miRNA expression profile determined using microarray analysis. Compared with healthy controls, a total of 44 miRNAs were upregulated and 57 miRNAs were downregulated. Among the dysregulated miRNAs, eight were significantly upregulated while five miRNAs were significantly downregulated, as determined by t-test (P < 0.05). Four of the significantly dysregulated miRNAs, including miR-221, miR-155, miR-100 and hsa-miR-1273, were selected and verified by real-time PCR. The real-time PCR results were consistent with the microarray data that miR-221, miR-155 and miR-100 were significantly downregulated in plaques, whereas miR-1273 was significantly upregulated. These results indicate that miRNAs expression level can be used as potential markers for early coronary atherosclerotic plaque formation. Copyright © 2015. Published by Elsevier Inc.
    Preview · Article · Jul 2015 · Biochemical and Biophysical Research Communications
  • Source
    • "These miRNA include miR-206, miR-145, miR-143 and miR-221, all of which have been shown to regulate vascular smooth muscle cell proliferation, migration and differentiation , affecting vasculature phenotypic building (Cordes et al. 2009; Boettger et al. 2009; Davis et al. 2009; Liu et al. 2009; Cheng and Zhang 2010; Caruso et al. 2012; Jalali et al. 2012). Moreover, miR-204, miR-155, miR-146 and miR-125a-5p regulated the vascular pathological reaction depending on the related mononuclear cells and inflammatory factor (Taganov et al. 2006; Ceppi et al. 2009; Chen et al. 2009; Shen et al. 2010; Courboulin et al. 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Coronary artery disease (CAD) and pulmonary arterial hypertension (PAH) are two of the most dangerous vascular diseases. Their etiology and pathogenesis are not yet fully understood, thus it remains difficult to achive great advance in the diagnose, therapy and prognosis techniques. microRNAs (miRNAs), a class of highly conserved, small, noncoding RNAs, critically mediate the post-transcriptional gene modulation, which regulates an array of important physiopathological processes including those occurring in cardiac and pulmonary systems. Thereby manipulation of miRNA expression could potentially be applied therapeutically. In this review, we summarize the current knowledge on the roles of miRNAs in the development of vascular diseases, especially in CAD and PAH, providing a theoretical basis for potential uses of miRNA in diagnosis, prognosis, and therapy in these cardiovascular diseases.
    Full-text · Article · Sep 2014 · Biocontrol Science and Technology
Show more